Induction of unresponsiveness to skin and heart allografts in mice by a synergistic treatment with procarbazine, antilymphocyte serum, and donor-type cells.
D000818:Animals; D000961:Antilymphocyte Serum / Q000008:administration & dosage*; D001853:Bone Marrow / Q000276:immunology; D001854:Bone Marrow Cells; D016026:Bone Marrow Transplantation; D003520:Cyclophosphamide / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D006084:Graft Rejection; D006087:Graft vs Host Reaction / Q000187:drug effects; D016027:Heart Transplantation; D007165:Immunosuppression Therapy; D051379:Mice; D008807:Mice, Inbred BALB C; D008808:Mice, Inbred CBA; D011344:Procarbazine / Q000008:administration & dosage; D016038:Skin Transplantation; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum; D011344:Procarbazine; D003520:Cyclophosphamide